[Evidence report for the S3 guideline on diagnosis and treatment of gout: treatment of comorbidities]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005405
German
Original Title: Behandlung von Komorbiditäten: Evidenzbericht zur S3-Leitlinie Diagnostik und Therapie der Gicht
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/v22-06.html
Year Published: 2023
URL for published report: https://www.iqwig.de/download/v22-06e_behandlung-von-komorbiditaeten_evidenzbericht_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://dx.doi.org/10.60584/V22-06E
MeSH Terms
  • Gout
  • Gout Suppressants
  • Sodium Chloride Symporter Inhibitors
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Glucose Transporter 2 Inhibitors
  • Comorbidity
  • Disease Management
Keywords
  • Sodium Chloride Symporter Inhibitors
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Glucose Transporter 2 Inhibitors
  • Gout
  • Systematic Review
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.